A symposium for improving cancer treatment through better statistical methods
Stat4Onc Annual Symposium
This study is all about bringing together doctors and experts in statistics to share ideas and improve the way we test new cancer treatments, making sure that patients get the best care possible.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project ID | NIH-11067864 on NIH RePORTER |
What this research studies
This research organizes an annual symposium that brings together oncologists and statisticians to discuss and improve statistical methods used in cancer clinical trials. The event includes short courses and a scientific program aimed at fostering collaboration and innovation in cancer research. By addressing communication gaps and promoting the use of advanced statistical techniques, the symposium aims to enhance patient care and drug development in oncology. Participants will include professionals from academia, industry, and regulatory bodies, creating a comprehensive platform for knowledge exchange.
Who could benefit from this research
Good fit: Ideal candidates for participation would be oncology professionals, statisticians, and trainees interested in cancer research and treatment methodologies.
Not a fit: Patients who are not involved in oncology research or do not have access to the symposium may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective cancer treatments and improved patient outcomes through better-designed clinical trials.
How similar studies have performed: Similar initiatives have shown success in enhancing collaboration and improving clinical trial designs, indicating a promising approach to advancing cancer research.
Where this research is happening
Stanford, United States
- Stanford University — Stanford, United States (Active)
Researchers
- Principal investigator: Lu, Ying — Stanford University
- Study coordinator: Lu, Ying
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.